Tradition is for insiders to start selling in upper 6's Think Gilead is watching the open label arm of the Madrigal trial and is impressed with this class of drugs? I've seen Gilead pay over a billion for a NASH drug at an earlier stage with less than impressive results. The volume on this price move is impressive. Also like that Blackrock went above 5% on their holdings.
News 
Market Data 
Discover 
